Penn Radiology Oncologic Imaging: Optimizing Patient Care 2016 (Videos)

Cutting-Edge Oncologic Imaging: Optimizing Patient Care

Penn Radiology, in collaboration with leading experts from Nuclear Medicine, Gastroenterology, Pulmonology, Radiation, and Interventional Oncology, presents a comprehensive exploration of Oncologic Imaging. This in-depth program will delve into best practices, clinical applications, and the latest advancements in the field, including a dedicated focus on CT screening for lung cancer.

State-of-the-Art and Emerging Techniques

Magnetic Resonance Imaging (MRI)

Dr. Mark A. Rosen, an esteemed radiologist, will showcase the latest MRI technologies and their role in oncologic imaging. From detailed tissue characterization to functional imaging, this session will shed light on the cutting-edge applications of MRI.

Computed Tomography (CT)

Dr. Susan Hilton, an accomplished CT specialist, will demonstrate the evolution of CT imaging, highlighting its enhanced capabilities in detecting and staging various malignancies. Participants will gain insights into advanced scan techniques and image interpretation strategies.

Ultrasound (US)

Dr. Steven C. Horii, a renowned ultrasound expert, will explore the diagnostic value of ultrasound in oncologic imaging. This session will cover advanced techniques for tumor detection, staging, and guidance of interventional procedures.

Nuclear Medicine Imaging

Dr. Daniel A. Pryma, a specialist in Nuclear Medicine, will present the latest developments in SPECT/CT and PET/CT imaging. Attendees will learn about the application of radiotracers in oncologic diagnosis, therapy planning, and disease monitoring.

Tomosynthesis

Dr. Emily F. Conant, an expert in tomosynthesis, will introduce this innovative imaging technique and its potential in improving breast cancer detection. Participants will gain an understanding of its technical principles and clinical benefits.

Specialized Imaging Applications

Head and Neck Cancers

Dr. Laurie A. Loevner, a specialist in head and neck radiology, will provide an in-depth examination of imaging techniques used for the evaluation of sinonasal and skullbase neoplasia. Attendees will learn about the role of advanced MRI and CT imaging in diagnosing and managing these tumors.

Thyroid Cancer

Dr. Hanna M. Zafar, an endocrinologist, will discuss the role of ultrasound in detecting thyroid cancer. Participants will gain practical knowledge on the interpretation of ultrasound findings and the management of suspicious lesions.

CT Screening for Lung Cancer

Dr. Drew A. Torigian, a pulmonologist, will present the rationale and evidence supporting CT screening for lung cancer. Participants will learn about the benefits, risks, and controversies surrounding this screening modality.

Clinical Updates and Imaging Correlates

Immunotherapy and Imaging Correlates

Dr. Tara C. Gangadhar, an oncologist, will provide an update on immune-modulating therapeutics and their implications for oncologic imaging. Participants will gain insights into the role of imaging in evaluating the response to immunotherapy and monitoring disease progression.

Breast Cancer Staging and Imaging

Dr. Lilie Lin, a breast cancer specialist, will discuss the American Joint Committee on Cancer (AJCC) staging system and the role of imaging in guiding standard of care therapy. Participants will learn about the latest advancements in breast cancer imaging and their impact on treatment决策.

Thoracic Cancers

Dr. Susan Roth, a breast radiologist, will present the indications and applications of MRI and ultrasound imaging in the diagnosis and management of breast cancer. Participants will gain practical knowledge on the use of these imaging modalities for tumor detection, staging, and treatment monitoring.

Gastrointestinal (GI) Malignancies

Dr. Daniel A. Pryma, a GI specialist, will provide an update on the AJCC staging system for esophageal and gastric cancers and discuss the standard of care therapeutic options. Participants will gain insights into the imaging techniques used for the detection, staging, and monitoring of these malignancies.

Other Abdominal Malignancies

Dr. Anil Chauhan, a liver specialist, will present the latest advancements in liver imaging for primary and metastatic disease. Participants will learn about the role of MRI in diagnosing and characterizing liver lesions, as well as the indications for liver-directed therapy.

Neuroendocrine Tumors

Dr. David C. Metz, a neurologist, will discuss the diagnosis, management, and palliative care options for neuroendocrine tumors. Participants will gain an understanding of the imaging features of these tumors and the role of imaging in monitoring their response to therapy.

Melanoma and Musculoskeletal Malignancies

Dr. Daniel A. Pryma, an oncologist, will present an overview of melanoma, including staging, treatment options, and the implications for imaging. Dr. Madhura A. Desai, an orthopedic surgeon, will provide insights into the imaging patterns, treatment options, and potential pitfalls in diagnosing and managing musculoskeletal malignancies.